|
- 2019
Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin MutationsDOI: https://doi.org/10.1016/j.cmet.2019.01.002 Abstract: ? mTORC1 activation is seen basally in pericentral hepatocytes because of Wnt/β-catenin ? CTNNB1-mutated liver tumors are positive for GS and p-mTOR-S2448 ? CTNNB1-mutated hepatocellular cancers are addicted to mTORC1 for metabolism ? Targeting β-catenin-GS-mTORC1 axis in liver tumors may enable precision medicin
|